An Explainable AI driven Decision Support System for COVID-19 Diagnosis using Fused Classification and Segmentation

Niranjan, K; Kumar, Shivam; Vedanth, S; Chitrakala, S.

doi:10.1016/j.procs.2023.01.168

Cited by 8 publications

(17 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…ML was the most frequently used method to develop CDSS for COVID‐19 diagnosis. The most common ML methods in the reviewed studies were CNN 34–85 . In line with this result, other review studies also indicated CNN to be the most common method to develop a system for COVID‐19 diagnosis 23,25,27,28,30,100 .…”

Section: Discussionsupporting

confidence: 54%

“…These studies also recommended the use of CDSS in future research. Finally, 68 articles met all the inclusion criteria 5,17,34–99 . The flowchart of the selection process is shown in Figure 1.…”

Section: Resultsmentioning

confidence: 99%

“…Types of CDSS to assist in diagnosing COVID‐19 are shown in Figure 4. Most of the studies used ICDSS based on ML (nonknowledge‐based CDSS) ( n = 52 [76.5%]) 34–85 . In these studies, the most common methods for designing CDSS were CNN ( n = 33), 38,40–42,45–47,49–52,54,56–69,71,72,78,82–85 SVM ( n = 8), 35,36,39,43,44,54,56,57 RF ( n = 7), 34,35,37,39,42,44,55 and KNN ( n = 7) 36,37,39,42,43,55,56 (Table 1 and Appendix ).…”

Section: Resultsmentioning

confidence: 99%

“…Most studies used a combination of performance metrics to evaluate CDSS ( n = 40) (Appendix ). In most of these studies, accuracy ( n = 43), 35–40,42–47,49–69,71,72,76–78,80–83,85 sensitivity (recall) ( n = 35) 35–37,39,41–44,46,47,49–54,56,57,61,63–69,71,72,76,78,81–85 and F1‐score ( n = 26) 34–36,39,41–43,46,47,50,52–54,56,57,60,61,63,64,66,68,69,81,82,84,85 were used (Table 2). Other metrics for evaluating ICDSS based on ML were the Matthews correlation coefficient (MCC), 52,56,58 receiver operating characteristic (ROC) curve, 34,36,70 and so on (Appendix ).…”

Section: Resultsmentioning

confidence: 99%

“…The most frequently used method for this purpose was the ICDSS based on ML (nonknowledge‐based CDSS), followed by ICDSS based on ES (knowledge‐based CDSS). Most studies have indicated that using CDSS have positively impacted the accurate diagnosis of COVID‐19 5,17,34–62,64–84,86–90,92–99 …”

Section: Discussionmentioning

confidence: 99%

See 4 more Smart Citations

Clinical decision support systems (CDSS) in assistance to COVID‐19 diagnosis: A scoping review on types and evaluation methods

Ameri,

Salmanizadeh

et al. 2024

Health Science Reports

View full text Add to dashboard Cite

Background and AimsDue to the COVID‐19 pandemic, a precise and reliable diagnosis of this disease is critical. The use of clinical decision support systems (CDSS) can help facilitate the diagnosis of COVID‐19. This scoping review aimed to investigate the role of CDSS in diagnosing COVID‐19.MethodsWe searched four databases (Web of Science, PubMed, Scopus, and Embase) using three groups of keywords related to CDSS, COVID‐19, and diagnosis. To collect data from studies, we utilized a data extraction form that consisted of eight fields. Three researchers selected relevant articles and extracted data using a data collection form. To resolve any disagreements, we consulted with a fourth researcher.ResultsA search of the databases retrieved 2199 articles, of which 68 were included in this review after removing duplicates and irrelevant articles. The studies used nonknowledge‐based CDSS (n = 52) and knowledge‐based CDSS (n = 16). Convolutional Neural Networks (CNN) (n = 33) and Support Vector Machine (SVM) (n = 8) were employed to design the CDSS in most of the studies. Accuracy (n = 43) and sensitivity (n = 35) were the most common metrics for evaluating CDSS.ConclusionCDSS for COVID‐19 diagnosis have been developed mainly through machine learning (ML) methods. The greater use of these techniques can be due to their availability of public data sets about chest imaging. Although these studies indicate high accuracy for CDSS based on ML, their novelty and data set biases raise questions about replacing these systems as clinician assistants in decision‐making. Further studies are needed to improve and compare the robustness and reliability of nonknowledge‐based and knowledge‐based CDSS in COVID‐19 diagnosis.

show abstract

Section: Discussionsupporting

confidence: 54%

Section: Resultsmentioning

confidence: 99%